Elements-Continuous-Flow Platform for Coupling Reactions and Anti-viral Daclatasvir API Synthesis
Synthesis · 15.02.2024 · 56 (04) · 657-667
DOI: 10.1055/a-2022-2063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, erschienen am 15.02.2024. Verfasst von Srihari Pabbaraja und 6 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
A novel nanotextured Ni@Cu material embedded electro-microflow reactor with minimal electrode distance has been employed to synthesize biphenyls via the construction of a new C–C bond. The reported protocol is devoid of noble metals and involves co-reductant/oxidant-free conditions in a fast manner for the synthesis of substituted/unsubstituted biphenyl systems. The electro-reactor volume was optimized for gram-scale biphenyl synthesis and further extended for an integrated total process system reducing the tedious downstream process by selective removal of unwanted chemicals/solvent. The continuous microflow synthesis of daclatasvir has now been accomplished with a good yield.
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Pabbaraja, S., Singh, A. K., Mahajan, B., Aand, D., Purwa, M., Mujawar, T., & Ghosh, S. (2024). Elements-Continuous-Flow Platform for Coupling Reactions and Anti-viral Daclatasvir API Synthesis. Synthesis, 56(04), 657-667. https://doi.org/10.1055/a-2022-2063
Vancouver
Pabbaraja S, Singh AK, Mahajan B, Aand D, Purwa M, Mujawar T, et al. Elements-Continuous-Flow Platform for Coupling Reactions and Anti-viral Daclatasvir API Synthesis. Synthesis. 2024;56(04):657-667. doi:10.1055/a-2022-2063
BibTeX
@article{Pabbaraja2024,
author = {Pabbaraja, Srihari and Singh, Ajay K. and Mahajan, Bhushan and Aand, Dnyaneshwar and Purwa, Mandeep and Mujawar, Taufiqueahmed and Ghosh, Subhash},
title = {Elements-Continuous-Flow Platform for Coupling Reactions and Anti-viral Daclatasvir API Synthesis},
journal = {Synthesis},
year = {2024},
volume = {56},
number = {04},
pages = {657--667},
doi = {10.1055/a-2022-2063}
}
EUVIMED